Skip to content
HeyJared

Meeting Mic

While annual major scientific meetings are the venue to stay up-to-date in your clinical area, it is near impossible to attend all breaking news sessions.

Podcast · By Healio · English · Official site

Indexed episodes, last 90 days
3
Latest publication
Aug 3, 2026
Audience
Checking…
Earliest in this view
Jul 6, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest episodes

  1. Episode · Aug 3, 2026

    Highlights from ASRS 2026 (opens the original)

    Episode notes · Positive tone

    Read excerpt

    In this episode of Meeting Mic, we bring you pearls and perspectives from the American Society of Retina Specialists Annual Meeting. In an interview, Anat Loewenstein, MD, MHA, of Tel Aviv Medical Center, talks about how Home OCT combined with an AI analysis helped in the early detection of retinal fluid in patients with age-related macular degeneration. Next, David Almeida, MD, MBA, PhD, of Erie Retina Research in Pennsylvania, talks about how CG-P5, a topical peptide eye drop, met safety and e

  2. Episode · Jul 13, 2026

    Highlights in acute myeloid leukemia from ASCO 2026 (opens the original)

    Episode notes · Neutral tone

    Read excerpt

    In this episode of Meeting Mic, Oncology Overdrive host, Shikha Jain, MD, is joined by Akriti Jain, MD, to discuss innovations in the management of acute myeloid leukemia, as well as highlights and abstracts from ASCO Annual Meeting. · What advances have you seen in AML care over the past 10 to 12 years? 5:57 · How do you manage treatment of patients with TP53 -mutated AML? 13:39 · What types of disparities do you see in your patient populations? 15:48 · What advice do you give patients to help

  3. Episode · Jul 6, 2026

    Breast cancer highlights from ASCO 2026 (opens the original)

    Episode notes

    Read excerpt

    In this episode of Meeting Mic, we bring you pearls and perspectives in breast cancer from ASCO Annual Meeting. In an interview, Jame Abraham, MD, discusses the DESTINY-Breast05 study, as well as clinical and demographic risk factors for interstitial lung disease and radiation pneumonitis. Next, Shimoli Barot, MD, discusses results from the phase 3 lidERA BC clinical trial of premenopausal vs. postmenopausal women with breast cancer. Sara A. Hurvitz, MD, FACP, provides an overview of the ASCENT-

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Not enough subject data for this period yet.

Audience

No verified audience measurement yet.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Meeting Mic